Exploiting the defensive sugars of HIV-1 for drug and vaccine design

Exploiting the defensive sugars of HIV-1 for drug and vaccine design

The sustained effort towards developing an antibody vaccine against HIV/AIDS has provided much of our understanding of viral immunology. It is generally accepted that one of the main barriers to antibody neutralization of HIV is the array of protective structural carbohydrates that covers the antige...

Szczegółowa specyfikacja

Opis bibliograficzny
Główni autorzy:	Scanlan, C, Offer, J, Zitzmann, N, Dwek, R
Format:	Journal article
Język:	English
Wydane:	Nature Research 2007

Podobne zapisy

Emerging principles for the therapeutic exploitation of glycosylation.
od: Dalziel, M, i wsp.
Wydane: (2014)

Sugar immunogens
od: Dwek, R, i wsp.
Wydane: (2009)

Antigenic mimicry of the HIV envelope by AIDS-Associated pathogens
od: Dunlop, D, i wsp.
Wydane: (2008)

Antigenic mimicry of the HIV envelope by AIDS-associated pathogens.
od: Dunlop, D, i wsp.
Wydane: (2008)

Yeast mannan genetics controls the molecular specificity of anti-carbohydrate antibodies cross-reactive to the HIV envelope
od: Dunlop, D, i wsp.
Wydane: (2009)

Glycobiology against viruses: Antiviral drug discovery
od: Zitzmann, N, i wsp.
Wydane: (2006)

P05-11. Yeast mannan genetics controls the molecular specificity of anti-carbohydrate antibodies cross-reactive to the HIV envelope
od: Dwek R, i wsp.
Wydane: (2009-10-01)

Inhibition of HIV replication by amino-sugar derivatives.
od: Fleet, G, i wsp.
Wydane: (1988)

N-Butyldeoxynojirimycin is a broadly effective anti-HIV therapy significantly enhanced by targeted liposome delivery.
od: Pollock, S, i wsp.
Wydane: (2008)

Liposome treatment of viral infections
od: Dwek, R, i wsp.
Wydane: (2011)

Host-targeting oral antiviral drugs to prevent pandemics
od: Dwek, RA, i wsp.
Wydane: (2022)

Inhibition of mammalian glycan biosynthesis produces non-self antigens for a broadly neutralising, HIV-1 specific antibody.
od: Scanlan, C, i wsp.
Wydane: (2007)

Clinical diagnosis of hepatic fibrosis using human serum APOL1 as biomarker
od: Gangadharan, B, i wsp.
Wydane: (2012)

Imino sugar therapy for type 1 Gaucher disease.
od: Priestman, D, i wsp.
Wydane: (2000)

Exploiting B Cell Receptor Analyses to Inform on HIV-1 Vaccination Strategies
od: Christoph Kreer, i wsp.
Wydane: (2020-01-01)

Polyunsaturated liposomes are antiviral against hepatitis B and C viruses and HIV by decreasing cholesterol levels in infected cells.
od: Pollock, S, i wsp.
Wydane: (2010)

Use of iminosugar derivatives to inhibit ion channel activity
od: Zitzmann, N, i wsp.
Wydane: (2004)

Molecular mechanisms for enhancing the antigenicity of the carbohydrate epitope of the broadly neutralizing anti-HIV-1 antibody 2G12
od: Fulton, Z, i wsp.
Wydane: (2009)

Defensive Driving: Directing HIV-1 Vaccine-Induced Humoral Immunity to the Mucosa with Chemokine Adjuvants
od: Ebony N. Gary, i wsp.
Wydane: (2018-01-01)

Endoplasmic reticulum targeting liposomes
od: Pollock, S, i wsp.
Wydane: (2011)

Cholesterol level lowering liposomes
od: Pollock, S, i wsp.
Wydane: (2012)

Imino sugar inhibitors for treating the lysosomal glycosphingolipidoses.
od: Butters, T, i wsp.
Wydane: (2005)

Sugar and enzymes: Exploring and exploiting protein-carbohydrate interactions
od: Davis, B
Wydane: (2006)

Sugars and enzymes: Exploring and exploiting protein-carbohydrate interactions.
od: Davis, B
Wydane: (2005)

Sugars and enzymes: Exploring and exploiting protein-carbohydrate interactions
od: Davis, B
Wydane: (2005)

A nonself sugar mimic of the HIV glycan shield shows enhanced antigenicity.
od: Doores, K, i wsp.
Wydane: (2010)

The influence of different lipid environments on the structure and function of the hepatitis C virus p7 ion channel protein
od: Whitfield, T, i wsp.
Wydane: (2011)

Imino sugars inhibit the formation and secretion of bovine viral diarrhea virus, a pestivirus model of hepatitis C virus: Implications for the development of broad spectrum anti-hepatitis virus agents
od: Zitzmann, N, i wsp.
Wydane: (1999)

Therapeutic applications of imino sugars in lysosomal storage disorders.
od: Butters, T, i wsp.
Wydane: (2003)

Hardware-assisted online defense against malware and exploits
od: Das, Sanjeev Kumar
Wydane: (2016)

Exploiting viral properties for the rational design of modern vaccines.
od: Spohn, G, i wsp.
Wydane: (2008)

Proteomics in uveal melanoma research: opportunities and challenges in biomarker discovery.
od: Pardo, M, i wsp.
Wydane: (2007)

Clinical diagnosis of hepatic fibrosis using a novel panel of low abundant human plasma protein biomarkers
od: Gangadharan, B, i wsp.
Wydane: (2010)

Clinical diagnosis of hepatic fibrosis using a novel panel of human serum protein biomarkers
od: Gangadharan, B, i wsp.
Wydane: (2008)

Exploitation of Unconventional CD8 T-Cell Responses Induced by Engineered Cytomegaloviruses for the Development of an HIV-1 Vaccine
od: Joseph Bruton, i wsp.
Wydane: (2025-01-01)

The Case for Exploiting Cross-Species Epitopes in Malaria Vaccine Design
od: Catherine J. Mitran, i wsp.
Wydane: (2020-02-01)

The carbohydrate epitope of the neutralizing anti-HIV-1 antibody 2G12.
od: Scanlan, C, i wsp.
Wydane: (2003)

Sugar-mediated ligand-receptor interactions in the immune system.
od: Rudd, P, i wsp.
Wydane: (2004)

The silent defense: Micro-RNA directed defense against HIV-1 replication
od: Kumar Ajit
Wydane: (2007-04-01)

Exploitation of Documented Historical Floods for Achieving Better Flood Defense
od: Slobodan Kolaković, i wsp.
Wydane: (2016-01-01)